Department of Orthopaedic Surgery, Washington University, St. Louis, Missouri, USA.
Shriners Hospitals for Children-St. Louis, St. Louis, Missouri, USA.
Stem Cells. 2019 Jan;37(1):65-76. doi: 10.1002/stem.2931. Epub 2018 Oct 31.
The differentiation of human induced pluripotent stem cells (hiPSCs) to prescribed cell fates enables the engineering of patient-specific tissue types, such as hyaline cartilage, for applications in regenerative medicine, disease modeling, and drug screening. In many cases, however, these differentiation approaches are poorly controlled and generate heterogeneous cell populations. Here, we demonstrate cartilaginous matrix production in three unique hiPSC lines using a robust and reproducible differentiation protocol. To purify chondroprogenitors (CPs) produced by this protocol, we engineered a COL2A1-GFP knock-in reporter hiPSC line by CRISPR-Cas9 genome editing. Purified CPs demonstrated an improved chondrogenic capacity compared with unselected populations. The ability to enrich for CPs and generate homogenous matrix without contaminating cell types will be essential for regenerative and disease modeling applications. Stem Cells 2019;37:65-76.
人诱导多能干细胞(hiPSCs)向特定细胞命运的分化使工程特定于患者的组织类型成为可能,例如透明软骨,用于再生医学、疾病建模和药物筛选。然而,在许多情况下,这些分化方法控制不佳并且产生异质细胞群体。在这里,我们使用稳健且可重复的分化方案展示了三种独特的 hiPSC 系中的软骨基质产生。为了纯化该方案产生的软骨祖细胞(CPs),我们通过 CRISPR-Cas9 基因组编辑工程设计了 COL2A1-GFP 敲入报告 hiPSC 系。与未选择的群体相比,纯化的 CPs 表现出改善的软骨生成能力。富集 CPs 并生成无混杂细胞类型的同质基质的能力对于再生和疾病建模应用将是必不可少的。干细胞 2019;37:65-76。